PPARs Link Early Life Nutritional Insults to Later Programmed Hypertension and Metabolic Syndrome

PPARs Link Early Life Nutritional Insults to Later Programmed Hypertension and Metabolic Syndrome

Hypertension is an important component of metabolic syndrome. Adulthood hypertension and metabolic syndrome can be programmed in response to nutritional insults in early life. Peroxisome proliferator-activated receptors (PPARs) serve as a nutrient-sensing signaling linking nutritional programming to...

Full description

Bibliographic Details
Main Authors:	You-Lin Tain, Chien-Ning Hsu, Julie Y. H. Chan
Format:	Article
Language:	English
Published:	MDPI AG 2015-12-01
Series:	International Journal of Molecular Sciences
Subjects:	developmental programming hypertension kidney metabolic syndrome nutrient sensing peroxisome proliferator-activated receptor
Online Access:	http://www.mdpi.com/1422-0067/17/1/20

Similar Items

Renal Transcriptome Analysis of Programmed Hypertension Induced by Maternal Nutritional Insults
by: You-Lin Tain, et al.
Published: (2015-08-01)

Maternal Fructose Intake Affects Transcriptome Changes and Programmed Hypertension in Offspring in Later Life
by: You-Lin Tain, et al.
Published: (2016-11-01)

AMP-Activated Protein Kinase as a Reprogramming Strategy for Hypertension and Kidney Disease of Developmental Origin
by: You-Lin Tain, et al.
Published: (2018-06-01)

Amino Acids and Developmental Origins of Hypertension
by: Chien-Ning Hsu, et al.
Published: (2020-06-01)

Maternal Melatonin Therapy Attenuates Methyl-Donor Diet-Induced Programmed Hypertension in Male Adult Rat Offspring
by: You-Lin Tain, et al.
Published: (2018-10-01)

Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity
by: Ayza MA, et al.
Published: (2020-10-01)

Regulation of Nitric Oxide Production in the Developmental Programming of Hypertension and Kidney Disease
by: Chien-Ning Hsu, et al.
Published: (2019-02-01)

Early-Life Programming and Reprogramming of Adult Kidney Disease and Hypertension: The Interplay between Maternal Nutrition and Oxidative Stress
by: Chien-Ning Hsu, et al.
Published: (2020-05-01)

The Double-Edged Sword Effects of Maternal Nutrition in the Developmental Programming of Hypertension
by: Chien-Ning Hsu, et al.
Published: (2018-12-01)

The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function
by: Gray Elizabeth, et al.
Published: (2012-04-01)

The Role of PPARs in Disease
by: Nicole Wagner, et al.
Published: (2020-10-01)

Oleamide activates peroxisome proliferator-activated receptor gamma (PPARγ) <it>in vitro</it>
by: Dionisi Mauro, et al.
Published: (2012-05-01)

Fenretinide inhibits macrophage inflammatory mediators and controls hypertension in spontaneously hypertensive rats via the peroxisome proliferator-activated receptor gamma pathway
by: Lin CH, et al.
Published: (2016-11-01)

Gasotransmitters for the Therapeutic Prevention of Hypertension and Kidney Disease
by: Chien-Ning Hsu, et al.
Published: (2021-07-01)

PPARα contributes to protection against metabolic and inflammatory derangements associated with acute kidney injury in experimental sepsis
by: Takuma Iwaki, et al.
Published: (2019-05-01)

Maternal Melatonin Therapy Attenuated Maternal High-Fructose Combined with Post-Weaning High-Salt Diets-Induced Hypertension in Adult Male Rat Offspring
by: You-Lin Tain, et al.
Published: (2018-04-01)

Peroxisome proliferator-activated receptors-γ and hypertension: Lessons of the history of researches
by: M S Rasin
Published: (2013-09-01)

PPAR Beta/Delta and the Hallmarks of Cancer
by: Nicole Wagner, et al.
Published: (2020-05-01)

Developmental Programming and Reprogramming of Hypertension and Kidney Disease: Impact of Tryptophan Metabolism
by: Chien-Ning Hsu, et al.
Published: (2020-11-01)

Evaluation of peroxisome proliferator-activated receptor-gamma (Ppar-γ) and metabolic dysfunction among hypertensive nigerians
by: Oloruntoba Ayodele Ekun, et al.
Published: (2021-12-01)

Whether AICAR in Pregnancy or Lactation Prevents Hypertension Programmed by High Saturated Fat Diet: A Pilot Study
by: Wan-Long Tsai, et al.
Published: (2020-02-01)

Role of GW0742 A PPARβ/δ Agonist on Coronary Angiogenesis in Control and Diabetic Rats
by: Ensieh Salehi, et al.
Published: (2011-08-01)

Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
by: Paterniti Irene, et al.
Published: (2013-02-01)

Maternal High Fructose Intake Increases the Vulnerability to Post-Weaning High-Fat Diet-Induced Programmed Hypertension in Male Offspring
by: You-Lin Tain, et al.
Published: (2018-01-01)

A Selective PPARγ Modulator Reduces Hepatic Fibrosis
by: Benita L. McVicker, et al.
Published: (2020-07-01)

When Activator and Inhibitor of PPARα Do the Same: Consequence for Differentiation of Human Intestinal Cells
by: Katerina Cizkova, et al.
Published: (2021-09-01)

The Interplay between Maternal and Post-Weaning High-Fat Diet and Gut Microbiota in the Developmental Programming of Hypertension
by: Chien-Ning Hsu, et al.
Published: (2019-08-01)

Ablation of Selenbp1 Alters Lipid Metabolism via the Pparα Pathway in Mouse Kidney
by: Yingxia Song, et al.
Published: (2021-05-01)

Fenofibrate, a ligand for PPARα, inhibits aromatase cytochrome P450 expression in the ovary of mouse
by: Katsumi Toda, et al.
Published: (2003-02-01)

Clinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPARγ deficiency[S]
by: Philippe M. Campeau, et al.
Published: (2012-09-01)

Effect of berberine on PPARα-NO signalling pathway in vascular smooth muscle cell proliferation induced by angiotensin IV
by: Hongmei Qiu, et al.
Published: (2017-01-01)

Targeting the Renin–Angiotensin–Aldosterone System to Prevent Hypertension and Kidney Disease of Developmental Origins
by: Chien-Ning Hsu, et al.
Published: (2021-02-01)

Retinal homeostasis and metformin-induced protection are not affected by retina-specific Pparδ knockout
by: Lei Xu, et al.
Published: (2020-10-01)

The effects of hydroxysafflor yellow A on PPARγ expression in glutamate⁃induced neuron damage
by: Xing⁃miao LIU, et al.
Published: (2012-06-01)

Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Trophoblast Functions
by: Lin Peng, et al.
Published: (2021-01-01)

Mechanistic Insight into PPARγ and Tregs in Atherosclerotic Immune Inflammation
by: Zhao Gao, et al.
Published: (2021-09-01)

The Effect of Peroxisome Proliferator-Activated Receptors (PPARs) in Male Fertility
by: Motahareh Sadat Mousavi, et al.
Published: (2020-09-01)

Attenuation of high-fat diet-induced fatty liver through PPARα activation by stevioside
by: Chang-Hao Jia, et al.
Published: (2019-06-01)

GW9662, an antagonist of PPAR-gamma, inhibits breast tumour cell growth and promotes the anticancer effects of the PPAR-gamma agonist Rosiglitazone, independently of PPAR-gamma activation.
by: Gill, Jason H., et al.
Published: (2009)

SARTANS OF THE SECOND GENERATION: THERAPEUTIC POTENTIAL EXTENSION
by: S. V. Nedogoda
Published: (2016-01-01)